Does BOTULINUM TOXIN TYPE A Cause C-reactive protein abnormal? 266 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 266 reports of C-reactive protein abnormal have been filed in association with BOTULINUM TOXIN TYPE A (Jeuveau). This represents 7.1% of all adverse event reports for BOTULINUM TOXIN TYPE A.
266
Reports of C-reactive protein abnormal with BOTULINUM TOXIN TYPE A
7.1%
of all BOTULINUM TOXIN TYPE A reports
264
Deaths
265
Hospitalizations
How Dangerous Is C-reactive protein abnormal From BOTULINUM TOXIN TYPE A?
Of the 266 reports, 264 (99.2%) resulted in death, 265 (99.6%) required hospitalization, and 263 (98.9%) were considered life-threatening.
Is C-reactive protein abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BOTULINUM TOXIN TYPE A. However, 266 reports have been filed with the FAERS database.
What Other Side Effects Does BOTULINUM TOXIN TYPE A Cause?
Off label use (1,785)
Drug ineffective (1,175)
Drug intolerance (1,004)
Product use in unapproved indication (950)
Headache (797)
Migraine (775)
Maternal exposure during pregnancy (716)
Pain (714)
Hypoaesthesia (703)
Nausea (665)
What Other Drugs Cause C-reactive protein abnormal?
METHOTREXATE (3,734)
ADALIMUMAB (3,629)
ETANERCEPT (3,592)
ABATACEPT (3,402)
LEFLUNOMIDE (3,279)
TOCILIZUMAB (3,259)
HYDROXYCHLOROQUINE (3,245)
SULFASALAZINE (2,823)
INFLIXIMAB (2,676)
RITUXIMAB (2,608)
Which BOTULINUM TOXIN TYPE A Alternatives Have Lower C-reactive protein abnormal Risk?
BOTULINUM TOXIN TYPE A vs BREMELANOTIDE
BOTULINUM TOXIN TYPE A vs BRENTUXIMAB
BOTULINUM TOXIN TYPE A vs BRENTUXIMAB VEDOTIN
BOTULINUM TOXIN TYPE A vs BREO ELLIPTA
BOTULINUM TOXIN TYPE A vs BREXANOLONE